In addition to lowering risk of heart disease, maintaining a heart-healthy lifestyle may pay off in lower risk for developing cancer, researchers from Harvard-affiliated Massachusetts General Hospital (MGH) and other centers in the United States and the Netherlands have found. Looking at the potential link between cardiovascular disease (CVD) and cancer among participants in two… Read More »
One of the most common causes of hereditary cancer, Lynch syndrome affects some 1.1 million Americans, who face a lifetime risk of colorectal cancer as high as 80 percent as well as elevated rates of many other cancers, including of the endometrium, kidneys, ovaries and prostate. Patients seldom learn they carry the mutations associated with… Read More »
FDA Approves Vitrakvi (larotrectinib) for TRK Fusion Cancers Print this page November 26, 2018 — The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker). This is the second time the agency has approved a cancer treatment… Read More »
Through the past 20 years of clinical trials with cancer patient care experience, I summed up a few unexpected anticancer habits. Do not wear high heels. Inflammation is the body’s healing process, but long-term inflammation may lead to heart disease, autoimmune diseases, diabetes and increased risk of cancer. Wear some uncomfortable and inappropriate shoes can… Read More »